A Study to Assess the Pharmacodynamics of Lemborexant in Korean Participants With Insomnia Disorder
Clinical trial NCT05594589 · COMPLETED
Trial details
- NCT number
- NCT05594589
- Sponsor
- Eisai Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-30
- Primary completion
- 2024-04-26
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.